COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021

Detalhes bibliográficos
Autor(a) principal: Azevedo, João Araújo
Data de Publicação: 2023
Outros Autores: Lima, Ricardo, Cernadas, Rui
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.25756/rpf.v14i2.297
Resumo: Introduction: The COVID-19 pandemic has had a significant impact at several levels, particularly on health care systems. Until 13th March, Direção-Geral da Saúde confirmed 814 257 SARS-CoV-2 cases. The purpose of this paper was to characterize the confirmed infection employees’ group.Material and Methods: This is a cross-sectional study, descriptive with an analytical component that aims to explain the relationship between demographic variables (gender, age), clinical (comorbidities, disease severity) and labor variables (work regime, access to work) and the incidence of SARS-CoV-2 infection in an industrial company in the period between March 2020 and March 2021. Workers with confirmed SARS-CoV-2 infection by March 2021 were invited to answer a questionnaire. A bivariate statistical analysis was performed. The variables studied were: gender, age, associated comorbidities (hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, stroke, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, and oncological disease), disease severity (asymptomatic, symptomatic without or with the need for hospitalization), context of the infection (family, work, social), work regime (fixed daytime shifts) and means of transport (individual, shared or public).Results: In the period under review, 266 positive cases of COVID-19 were registered in a universe of 2098 workers. The company has 79% of employees in rotating shifts. In this group there was an incidence of the disease of 12.57%, having been 13.10% in workers on a fixed day shift. The positive cases were aged between 19 and 64 years, with an average age of 37.28 years. Most positive cases showed symptoms but did not require hospitalization (77.44%). The mean number of days with symptoms was 13.92, with 45 days being the maximum number. About 27% of workers reported symptoms after clinical discharge. Dyslipidemia was the most prevalent comorbidity (7.52% of those infected). Arterial hypertension was present in 6.77% of the workers, diabetes mellitus in 2.63% and chronic obstructive pulmonary disease in 1.88%. Of the study population, five employees reported a history of neoplasia, with 2 still undergoing treatments. Conclusion: In this study, a correlation was identified between age and maintenance of symptoms, with the more advanced the age of employees infected with SARS-CoV-2, the greater the probability of having symptoms for a longer period. The severity of the disease (asymptomatic, symptomatic without or with the need for hospitalization) was also related with the duration of the symptoms, and the more severe the clinical picture, the greater the likelihood that the symptoms would persist for longer.
id RCAP_d3f8b60d77d5734ce660309ee55bc10a
oai_identifier_str oai:ojs.farmacoterapia.pt:article/372
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021Caracterização de Casos COVID-19 numa Empresa da Indústria Automóvel, 2020-2021Introduction: The COVID-19 pandemic has had a significant impact at several levels, particularly on health care systems. Until 13th March, Direção-Geral da Saúde confirmed 814 257 SARS-CoV-2 cases. The purpose of this paper was to characterize the confirmed infection employees’ group.Material and Methods: This is a cross-sectional study, descriptive with an analytical component that aims to explain the relationship between demographic variables (gender, age), clinical (comorbidities, disease severity) and labor variables (work regime, access to work) and the incidence of SARS-CoV-2 infection in an industrial company in the period between March 2020 and March 2021. Workers with confirmed SARS-CoV-2 infection by March 2021 were invited to answer a questionnaire. A bivariate statistical analysis was performed. The variables studied were: gender, age, associated comorbidities (hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, stroke, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, and oncological disease), disease severity (asymptomatic, symptomatic without or with the need for hospitalization), context of the infection (family, work, social), work regime (fixed daytime shifts) and means of transport (individual, shared or public).Results: In the period under review, 266 positive cases of COVID-19 were registered in a universe of 2098 workers. The company has 79% of employees in rotating shifts. In this group there was an incidence of the disease of 12.57%, having been 13.10% in workers on a fixed day shift. The positive cases were aged between 19 and 64 years, with an average age of 37.28 years. Most positive cases showed symptoms but did not require hospitalization (77.44%). The mean number of days with symptoms was 13.92, with 45 days being the maximum number. About 27% of workers reported symptoms after clinical discharge. Dyslipidemia was the most prevalent comorbidity (7.52% of those infected). Arterial hypertension was present in 6.77% of the workers, diabetes mellitus in 2.63% and chronic obstructive pulmonary disease in 1.88%. Of the study population, five employees reported a history of neoplasia, with 2 still undergoing treatments. Conclusion: In this study, a correlation was identified between age and maintenance of symptoms, with the more advanced the age of employees infected with SARS-CoV-2, the greater the probability of having symptoms for a longer period. The severity of the disease (asymptomatic, symptomatic without or with the need for hospitalization) was also related with the duration of the symptoms, and the more severe the clinical picture, the greater the likelihood that the symptoms would persist for longer.Introdução: A pandemia por COVID-19 teve um impacto muito significativo a vários níveis mas em particular nos serviços de saúde. Até 13 de março de 2022 a Direção-Geral da Saúde contabilizou um total de 814 257 casos confirmados de SARS-CoV-2. Este artigo teve como objetivo caracterizar o grupo de trabalhadores da Continental Mabor com infeção confirmada. Material e Métodos: Trata-se de um estudo transversal, descritivo com uma componente analítica que pretende explicar a relação entre variáveis demográficas (sexo, idade), clínicas (comorbilidades, severidade de doença), laborais (regime de trabalho, acesso ao trabalho) e a incidência de infeção por SARS-CoV-2 numa empresa industrial no período compreendido entre março 2020 e março 2021. Os trabalhadores com infeção por SARS-CoV-2 confirmada até março de 2021 foram convidados a responder a um questionário. Foi realizada uma análise estatística bivariada. Foram estudadas as seguintes variáveis: sexo, idade, comorbilidades associadas (hipertensão, diabetes mellitus, dislipidemia, coronariopatia, acidente vascular cerebral, doença pulmonar obstrutiva crónica, doença renal crónica, doença hepática crónica, doença oncológica), severidade da doença (assintomático, sintomático sem ou com necessidade de internamento), contexto da infeção (familiar, laboral, social), regime de trabalho (fixo diurno, por turnos) e meio de transporte (individual, partilhado ou público). Resultados: No período em análise foram registados 266 casos positivos de COVID-19 num universo de 2098 trabalhadores. A empresa apresenta 79% dos colaboradores em turnos rotativos. Neste grupo houve uma incidência da doença de 12,57%, tendo sido de 13,10% nos trabalhadores que fazem turno fixo diurno. Os casos positivos apresentaram idades compreendidas entre os 19 e os 64 anos, sendo a média de idades de 37,28 anos. A maioria dos casos positivos apresentaram sintomas, mas sem necessidade de internamento (77,44%). A média do número de dias com sintomas foi de 13,92 sendo que 45 dias foi o número máximo. Cerca de 27% dos trabalhadores reportaram sintomas após alta clínica. A dislipidemia foi a comorbilidade mais prevalente (7,52% dos infetados). A hipertensão arterial estava presente em 6,77% dos trabalhadores, a diabetes mellitus em 2,63% e a doença pulmonar obstrutiva crónica em 1,88%. Da população em estudo, cinco colaboradores reportaram antecedentes de neoplasia, estando dois ainda a realizar tratamentos.Conclusão: Neste estudo identificou-se uma correlação entre a idade e manutenção dos sintomas sendo que quanto mais avançada a idade dos colaboradores infetados por SARS-CoV-2 maior a probabilidade de apresentarem sintomatologia por um período mais prolongado. A gravidade da doença (assintomático, sintomático sem ou com necessidade de internamento) mostrou também estar relacionada com a duração dos sintomas, sendo que quanto mais severo o quadro clínico, maior a probabilidade de os sintomas persistirem por mais tempo.Formifarma2023-07-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.25756/rpf.v14i2.297https://doi.org/10.25756/rpf.v14i2.297Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 14 No 2 (2022): Abril/Maio/Junho; 8-12Revista Portuguesa de Farmacoterapia; v. 14 n. 2 (2022): Abril/Maio/Junho; 8-122183-73411647-354Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttp://revista.farmacoterapia.pt/index.php/rpf/article/view/372http://revista.farmacoterapia.pt/index.php/rpf/article/view/372/325Direitos de Autor (c) 2023 Revista Portuguesa de Farmacoterapiahttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessAzevedo, João AraújoLima, RicardoCernadas, Rui2023-09-01T04:35:26Zoai:ojs.farmacoterapia.pt:article/372Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:34:33.779915Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
Caracterização de Casos COVID-19 numa Empresa da Indústria Automóvel, 2020-2021
title COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
spellingShingle COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
Azevedo, João Araújo
title_short COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
title_full COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
title_fullStr COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
title_full_unstemmed COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
title_sort COVID-19 Cases Characterization in an Automotive Industry Company, 2020-2021
author Azevedo, João Araújo
author_facet Azevedo, João Araújo
Lima, Ricardo
Cernadas, Rui
author_role author
author2 Lima, Ricardo
Cernadas, Rui
author2_role author
author
dc.contributor.author.fl_str_mv Azevedo, João Araújo
Lima, Ricardo
Cernadas, Rui
description Introduction: The COVID-19 pandemic has had a significant impact at several levels, particularly on health care systems. Until 13th March, Direção-Geral da Saúde confirmed 814 257 SARS-CoV-2 cases. The purpose of this paper was to characterize the confirmed infection employees’ group.Material and Methods: This is a cross-sectional study, descriptive with an analytical component that aims to explain the relationship between demographic variables (gender, age), clinical (comorbidities, disease severity) and labor variables (work regime, access to work) and the incidence of SARS-CoV-2 infection in an industrial company in the period between March 2020 and March 2021. Workers with confirmed SARS-CoV-2 infection by March 2021 were invited to answer a questionnaire. A bivariate statistical analysis was performed. The variables studied were: gender, age, associated comorbidities (hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, stroke, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, and oncological disease), disease severity (asymptomatic, symptomatic without or with the need for hospitalization), context of the infection (family, work, social), work regime (fixed daytime shifts) and means of transport (individual, shared or public).Results: In the period under review, 266 positive cases of COVID-19 were registered in a universe of 2098 workers. The company has 79% of employees in rotating shifts. In this group there was an incidence of the disease of 12.57%, having been 13.10% in workers on a fixed day shift. The positive cases were aged between 19 and 64 years, with an average age of 37.28 years. Most positive cases showed symptoms but did not require hospitalization (77.44%). The mean number of days with symptoms was 13.92, with 45 days being the maximum number. About 27% of workers reported symptoms after clinical discharge. Dyslipidemia was the most prevalent comorbidity (7.52% of those infected). Arterial hypertension was present in 6.77% of the workers, diabetes mellitus in 2.63% and chronic obstructive pulmonary disease in 1.88%. Of the study population, five employees reported a history of neoplasia, with 2 still undergoing treatments. Conclusion: In this study, a correlation was identified between age and maintenance of symptoms, with the more advanced the age of employees infected with SARS-CoV-2, the greater the probability of having symptoms for a longer period. The severity of the disease (asymptomatic, symptomatic without or with the need for hospitalization) was also related with the duration of the symptoms, and the more severe the clinical picture, the greater the likelihood that the symptoms would persist for longer.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-05
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.25756/rpf.v14i2.297
https://doi.org/10.25756/rpf.v14i2.297
url https://doi.org/10.25756/rpf.v14i2.297
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv http://revista.farmacoterapia.pt/index.php/rpf/article/view/372
http://revista.farmacoterapia.pt/index.php/rpf/article/view/372/325
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Farmacoterapia
http://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Farmacoterapia
http://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Formifarma
publisher.none.fl_str_mv Formifarma
dc.source.none.fl_str_mv Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 14 No 2 (2022): Abril/Maio/Junho; 8-12
Revista Portuguesa de Farmacoterapia; v. 14 n. 2 (2022): Abril/Maio/Junho; 8-12
2183-7341
1647-354X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132072004026368